Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Frontal fibrosing alopecia (FFA) is a rare variant of lichen planopilaris characterized by symmetrical, progressive, band-like anterior hair loss of the scalp.
Biomarker and diagnostic research for frontal fibrosing alopecia has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
4 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and medical devices. Pipeline includes 1 PHASE4, 1 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
176 publications have been identified in PubMed for frontal fibrosing alopecia. Research spans Other (29%), Review / Meta-Analysis (24%), and Epidemiology / Natural History (19%).
Research Type | Count | % of Total |
|---|---|---|
Other research | 50 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 42 | 24% |
Disease patterns and progression | 34 | 19% |
Patient case studies | 17 | 10% |
Laboratory research | 11 | 6% |
Clinical study results | 10 | 6% |
Testing and diagnosis research | 7 | 4% |
New treatment approaches | 4 | 2% |
Kelati A (2026). [PMID: 41912188](https://pubmed.ncbi.nlm.nih.gov/41912188/). *Dermatol Pract Concept*. [Epidemiology / Natural History]
Baker NJ (2026). [PMID: 41925130](https://pubmed.ncbi.nlm.nih.gov/41925130/). *J Cutan Med Surg*. [Other]
Needle CD (2026). [PMID: 40967306](https://pubmed.ncbi.nlm.nih.gov/40967306/). *J Am Acad Dermatol*. [Basic Science / Preclinical]
Zac RI (2026). [PMID: 42155409](https://pubmed.ncbi.nlm.nih.gov/42155409/). *An Bras Dermatol*. [Basic Science / Preclinical]
Alenezi S (2026). [PMID: 39824360](https://pubmed.ncbi.nlm.nih.gov/39824360/). *J Am Acad Dermatol*. [Review / Meta-Analysis]
Gomez-Lara AR (2026). [PMID: 41482127](https://pubmed.ncbi.nlm.nih.gov/41482127/). *J Am Acad Dermatol*. [Epidemiology / Natural History]
Melián-Olivera A (2026). [PMID: 42257043](https://pubmed.ncbi.nlm.nih.gov/42257043/). *Skin Appendage Disord*. [Epidemiology / Natural History]
Pastor-Nieto MA (2026). [PMID: 41942283](https://pubmed.ncbi.nlm.nih.gov/41942283/). *Contact Dermatitis*. [Epidemiology / Natural History]
Silva DHM (2026). [PMID: 41903017](https://pubmed.ncbi.nlm.nih.gov/41903017/). *Dermatol Ther (Heidelb)*. [Clinical Trial Publication]
Lipner SR (2026). [PMID: 41581669](https://pubmed.ncbi.nlm.nih.gov/41581669/). *J Am Acad Dermatol*. [Other]